02410 TYK MEDICINES-B
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.97X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 1.4% | Net Margin | N/A |
| Total Debt/Equity | 37.7% | Return on Equity | N/A |
| Price/Book | 14.20X | Return on Assets | N/A |
| (HKD 19.100) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | -411.53 | -421.51 | -348.69 |
|---|---|---|---|
| Net Profit Growth (%) | +2.4 | -20.9 | N/A |
| Earnings Per Share (HKD) | -1.219 | -1.46 | -1.255 |
| Earnings Per Share Growth (%) | +16.5 | -16.3 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | 1.345 | N/A | N/A |
| Auditors' Opinion | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 0.107 | 0 | N/A | 44.242 |
| Operating Result | -387.928 | -383.171 | +1.2 | -311.802 |
| Profit Before Taxation | -387.928 | -383.171 | +1.2 | -311.802 |
| Profit /( Loss) After Taxation | -387.928 | -383.171 | +1.2 | -311.802 |
| Minority Interests | -0.973 | -0.744 | +30.8 | -0.809 |
| Net Profit | -386.955 | -382.427 | +1.2 | -310.993 |
| Earnings Per Share () | -1.2189 | -1.4597 | -16.5 | -1.2551 |
| Announcement Date | 2025-03-27 | 2024-08-12 | NA | 2024-08-12 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
